J & J Faces Criminal Probe over Asbestos in Baby Powder
The U.S. Justice Department is conducting a criminal investigation to determine if Johnson & Johnson misled the public about the possible presence of asbestos fibers and the resulting cancer risk in its talcum powder. According to Bloomberg News, a federal grand jury is examining whether company officials knew and denied their product once contained trace amounts of the toxic mineral. An ongoing regulatory investigation and thousands of lawsuits have coincided with the latest probe of the pharmaceutical giant. Johnson & Johnson is the world’s largest manufacturer of talc products, including its iconic Baby Powder...
Source: Asbestos and Mesothelioma News - July 15, 2019 Category: Environmental Health Authors: Walter Pacheco Source Type: news

Beagles Diagnosing Cancer ‘Could Work with Mesothelioma’
Specially trained beagles could one day detect mesothelioma by scent, according to the lead researcher of a recent study detailing the dog breed’s stunning accuracy with lung cancer. Dr. Thomas Quinn, clinical professor at the Lake Erie College of Osteopathic Medicine, believes the dogs could be equally effective with pleural mesothelioma, a rare cancer caused by asbestos exposure. “Absolutely, this could work with mesothelioma. There is no reason why it wouldn’t,” Quinn told The Mesothelioma Center at Asbestos.com. “That is another cancer with strong potential for this to work well.” The Journal of the America...
Source: Asbestos and Mesothelioma News - July 10, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

All Scottish mesothelioma patients to get dedicated nurse specialist
All patients in Scotland living with mesothelioma will be provided with a dedicated clinical nurse specialist under new plans to transform care. (Source: Nursing Times)
Source: Nursing Times - July 9, 2019 Category: Nursing Source Type: news

Avastin Improves Quality of Life for Mesothelioma Patients
A research team from France has documented the health-related quality-of-life benefits of adding Avastin (bevacizumab) to chemotherapy for pleural mesothelioma patients, endorsing its addition to standard-of-care treatment. The recent quality-of-life analysis was a secondary endpoint of an earlier, multicenter clinical trial in France that showed an almost three-month median survival improvement when adding Avastin. The latest study demonstrated that adding Avastin to cisplatin and Alimta (pemetrexed) did not negatively impact quality of life — a problem with several other cancers because of the increased toxicity. “Co...
Source: Asbestos and Mesothelioma News - July 8, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Mesothelioma deaths reach their peak
New figures reveal industry-related deaths will remain high until 2020 Related items fromOnMedica Human rights of disabled people 'being eroded' Care services 'on verge of collapse' Brexit could result in thousands of extra CVD deaths One in five patients in Wales struggled to get GP appointment last year Cars should be banned from around schools (Source: OnMedica Latest News)
Source: OnMedica Latest News - July 7, 2019 Category: UK Health Source Type: news